Connect with us
Bayer expands its Barcelona innovation hub with a new R&D area for health and agriculture, integrating 82 professionals to advance clinical trials and medicine safety. The...
Bayer reported €4.18 billion in third-quarter losses, mainly due to agricultural division asset impairment. Revenues fell 3.6% to €9.97 billion, with agriculture down 8.7% and pharmaceuticals...
BioNTech saw a sharp drop in profits, starting 2024 with a €315 million loss, down from a €502 million profit the previous year, and sales plummeting...
Bayer shares have managed to partially reduce the losses recorded at the opening. Two weeks ago, the German company announced that it was studying the spin-off...
In 2023, Bayer hoped to have a sales volume of between €51 billion and €52 billion, which is now reduced to between €48.5 billion and €49.5 billion,...
Bayer posted a profit of €2.99 billion in the first half of 2022, compared with a loss of €246 million in the first half of last...
The figures in the pharmaceuticals area are cemented especially by the performance of Bayer's cardiovascular treatments and for the prevention of age-related ophthalmological diseases. Another highlight...
According to the latest published accounts, Bayer's sales rose by 5% between January and September 2021 compared with the same period in 2020, to $37 billion...
The most sensational news came, on December 7th, from the Tübingen headquarters of Curevac, when its CEO Franz-Werner Haas announced the upcoming application for approval of...
Effectively ending their self-imposed halt this year, drugmakers will start the new year with drug price increases.